Immunmodulerende effekt af LongoVital hos patienter med recidiverende aftøs stomatit. 2

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Immunmodulerende effekt af LongoVital hos patienter med recidiverende aftøs stomatit. 2. / Pedersen, A; Klausen, B; Hougen, H P; Ryder, L; Winther, K.

In: Ugeskrift for Laeger, Vol. 153, No. 37, 1991, p. 2561-4.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Pedersen, A, Klausen, B, Hougen, HP, Ryder, L & Winther, K 1991, 'Immunmodulerende effekt af LongoVital hos patienter med recidiverende aftøs stomatit. 2', Ugeskrift for Laeger, vol. 153, no. 37, pp. 2561-4.

APA

Pedersen, A., Klausen, B., Hougen, H. P., Ryder, L., & Winther, K. (1991). Immunmodulerende effekt af LongoVital hos patienter med recidiverende aftøs stomatit. 2. Ugeskrift for Laeger, 153(37), 2561-4.

Vancouver

Pedersen A, Klausen B, Hougen HP, Ryder L, Winther K. Immunmodulerende effekt af LongoVital hos patienter med recidiverende aftøs stomatit. 2. Ugeskrift for Laeger. 1991;153(37):2561-4.

Author

Pedersen, A ; Klausen, B ; Hougen, H P ; Ryder, L ; Winther, K. / Immunmodulerende effekt af LongoVital hos patienter med recidiverende aftøs stomatit. 2. In: Ugeskrift for Laeger. 1991 ; Vol. 153, No. 37. pp. 2561-4.

Bibtex

@article{07c099e102524dcc89e2741a0a0e3801,
title = "Immunmodulerende effekt af LongoVital hos patienter med recidiverende aft{\o}s stomatit. 2",
abstract = "LongoVital (LV) (DK. reg. no. 5178/75) is a herbal-based tablet enriched with recommended doses of vitamins. Peripheral lymphocyte subsets: T-helper/CD4 (OKT4+) and T-suppressor/cytotoxic/CD8 (OKT8+) were studied quantitatively in 31 otherwise healthy patients with minor recurrent aphthous ulceration (RAU) during six months' daily LV intake in a double-blind, randomised, crossover 1-year study. Fourteen had had LV during the first six months (GrA) and 17 LV during the latter six months (GrB). OKT4+ percentages increased significantly during the LV period in both groups (p less than 0.05). OKT8+ percentages increased in both groups, however, only significantly in GrA (P less than 0.05). It is concluded that LV acts as an immunostimulator in patients with RAU and that the increase in T-lymphocyte subsets may account for the previously reported benefit of LV in RAU prevention.",
keywords = "Adult, Double-Blind Method, Female, Humans, Leukocyte Count, Male, Middle Aged, Plant Extracts, Recurrence, Stomatitis, Aphthous, T-Lymphocytes, Tablets, Vitamins",
author = "A Pedersen and B Klausen and Hougen, {H P} and L Ryder and K Winther",
year = "1991",
language = "Dansk",
volume = "153",
pages = "2561--4",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "37",

}

RIS

TY - JOUR

T1 - Immunmodulerende effekt af LongoVital hos patienter med recidiverende aftøs stomatit. 2

AU - Pedersen, A

AU - Klausen, B

AU - Hougen, H P

AU - Ryder, L

AU - Winther, K

PY - 1991

Y1 - 1991

N2 - LongoVital (LV) (DK. reg. no. 5178/75) is a herbal-based tablet enriched with recommended doses of vitamins. Peripheral lymphocyte subsets: T-helper/CD4 (OKT4+) and T-suppressor/cytotoxic/CD8 (OKT8+) were studied quantitatively in 31 otherwise healthy patients with minor recurrent aphthous ulceration (RAU) during six months' daily LV intake in a double-blind, randomised, crossover 1-year study. Fourteen had had LV during the first six months (GrA) and 17 LV during the latter six months (GrB). OKT4+ percentages increased significantly during the LV period in both groups (p less than 0.05). OKT8+ percentages increased in both groups, however, only significantly in GrA (P less than 0.05). It is concluded that LV acts as an immunostimulator in patients with RAU and that the increase in T-lymphocyte subsets may account for the previously reported benefit of LV in RAU prevention.

AB - LongoVital (LV) (DK. reg. no. 5178/75) is a herbal-based tablet enriched with recommended doses of vitamins. Peripheral lymphocyte subsets: T-helper/CD4 (OKT4+) and T-suppressor/cytotoxic/CD8 (OKT8+) were studied quantitatively in 31 otherwise healthy patients with minor recurrent aphthous ulceration (RAU) during six months' daily LV intake in a double-blind, randomised, crossover 1-year study. Fourteen had had LV during the first six months (GrA) and 17 LV during the latter six months (GrB). OKT4+ percentages increased significantly during the LV period in both groups (p less than 0.05). OKT8+ percentages increased in both groups, however, only significantly in GrA (P less than 0.05). It is concluded that LV acts as an immunostimulator in patients with RAU and that the increase in T-lymphocyte subsets may account for the previously reported benefit of LV in RAU prevention.

KW - Adult

KW - Double-Blind Method

KW - Female

KW - Humans

KW - Leukocyte Count

KW - Male

KW - Middle Aged

KW - Plant Extracts

KW - Recurrence

KW - Stomatitis, Aphthous

KW - T-Lymphocytes

KW - Tablets

KW - Vitamins

M3 - Tidsskriftartikel

C2 - 1949258

VL - 153

SP - 2561

EP - 2564

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 37

ER -

ID: 44355025